Novo Nordisk EVP happy to meet the US’ obesity drug demand

The pharmaceutical firm has actually spent billions in boosting its manufacturing of Wegovy and Ozempic in the United States to make sure adequate manufacturing to quit duplicate items from being offered on the marketplace.

发布者:BY EMIL ROMER OLSEN,转转请注明出处:https://robotalks.cn/novo-nordisk-evp-happy-to-meet-the-us-obesity-drug-demand/

(0)
上一篇 24 2 月, 2025 8:22 下午
下一篇 24 2 月, 2025 8:22 下午

相关推荐

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注

联系我们

400-800-8888

在线咨询: QQ交谈

邮件:admin@example.com

工作时间:周一至周五,9:30-18:30,节假日休息

关注微信
社群的价值在于通过分享与互动,让想法产生更多想法,创新激发更多创新。